Skip to content
Medical Health Aged Care

Community turns out in force to support people impacted by dementia

Dementia Australia 2 mins read

Thank you to Forster and Tuncurry community members who turned up in force to the 2024 Memory Walk & Jog, showing their support for Australians living with dementia.

 

More than100 people walked, ran and jogged on Saturday 11 May raising an impressive total of over $19,500!

 

Dementia Australia Executive Director Services, Advocacy and Research said it was a wonderful occasion and extended her gratitude to all who participated, raised funds, spread the word and donated.

 

“There was an outstanding show of support from the Forster and Tuncurry community who turned out in such large numbers for another year. So many people impacted by dementia find these events a great way to connect with others in similar circumstances. It is such an important day and your support means the world,” Dr Stokes said.

 

Dr Kaele also acknowledged everyone who volunteered at the Forster-Tuncurry Memory Walk & Jog.

“It is only through the hard work of our wonderful volunteers that the success of this event is possible.”

The Forster-Tuncurry event is one of the 22 scheduled Memory Walk & Jogs taking place across Australia in 2024. Details on the remaining events in the series can be found at www.memorywalk.com.au

Dementia Australia is encouraging anyone unable to participate at one of our 22 events to consider organising their own group or individual walk or jog, with a MyWay event. More details can be found at www.memorywalk.com.au/get-involved/mw.

 

Walk or jog with us. We are in this together.

 

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.  

 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au   

-Ends-

Media contacts: Andrea Hogan, Media and Communications Manager, 0406 904 118, [email protected]

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 22/01/2026
  • 23:11
Concept Medical Inc.

Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES

TAMPA, Fla.–BUSINESS WIRE– Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrollment of the first…

  • Contains:
  • Medical Health Aged Care
  • 22/01/2026
  • 22:11
Sinovac Biotech Ltd.

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies. Under the Panel’s decision, SINOVAC must, on or before May 11, 2026, demonstrate compliance with Nasdaq Listing Rule 5250(c)(1) and Listing Rule 5250(c)(2) by completing filings of its annual report for the year ended December 31, 2024 on Form 20-F and…

  • Medical Health Aged Care
  • 22/01/2026
  • 17:11
Galderma

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.